Importantly, Kaplan-Meier plotter analysis of published dataset [18] (www.kmplot.com) found that high expression level of MT1F could identify patients with an improved probability of relapse-free survival, supporting a tumor suppressive role of MT1F in GC (GSE15459: HR=0.54, [95% CI 0.33–0.89], Figure 4H; GSE22377: HR=0.44, [95% CI 0.2–0.97], Figure 4I). Here, MT1F is linked to gastric cancer.